SelectScience InterviewsDrug discovery > Lead Discovery
Flexible nanoscale options for IP drug delivery; targeting high grade serous ovarian cancer
18 Nov 2021![Flexible nanoscale options for IP drug delivery; targeting high grade serous ovarian cancer Flexible nanoscale options for IP drug delivery; targeting high grade serous ovarian cancer](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/98e55a98e2f71e1da3a86a71a731b2a2524a34c3-805x450.jpg?w=3840&q=75&fit=clip&auto=format)
Watch this presentation by Dr. Lewis Francis, associate professor, Swansea University Medical School, titled: Flexible nanoscale options for IP drug delivery; targeting high grade serous ovarian cancer. This talk was presented at the SelectScience® Virtual Biopharma Summit 2021.